...
首页> 外文期刊>Human Molecular Genetics >Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.
【24h】

Mechanism of action of a sulphonylurea receptor SUR1 mutation (F132L) that causes DEND syndrome.

机译:引起DEND综合征的磺酰脲受体SUR1突变(F132L)的作用机理。

获取原文
获取原文并翻译 | 示例

摘要

Activating mutations in the genes encoding the ATP-sensitive potassium (K(ATP)) channel subunits Kir6.2 and SUR1 are a common cause of neonatal diabetes. Here, we analyse the molecular mechanism of action of the heterozygous mutation F132L, which lies in the first set of transmembrane helices (TMD0) of SUR1. This mutation causes severe developmental delay, epilepsy and permanent neonatal diabetes (DEND syndrome). We show that the F132L mutation reduces the ATP sensitivity of K(ATP) channels indirectly, by altering the intrinsic gating of the channel. Thus, the open probability is markedly increased when Kir6.2 is co-expressed with mutant TMD0 alone or with mutant SUR1. The F132L mutation disrupts the physical interaction between Kir6.2 and TMD0, but does not alter the plasmalemma channel density. Our results explain how a mutation in an accessory subunit can produce enhanced activity of the K(ATP) channel pore (formed by Kir6.2). They also provide further evidence that interactions between TMD0 of SUR1and Kir6.2 are critical for K(ATP) channel gating and identify a residue crucial for this interaction at both physical and functional levels.
机译:编码ATP敏感性钾(K(ATP))通道亚基Kir6.2和SUR1的基因中的激活突变是新生儿糖尿病的常见原因。在这里,我们分析了杂合突变F132L作用的分子机制,该突变位于SUR1的第一组跨膜螺旋(TMD0)中。这种突变导致严重的发育迟缓,癫痫和永久性新生儿糖尿病(DEND综合征)。我们显示F132L突变通过更改通道的固有门控间接降低了K(ATP)通道的ATP敏感性。因此,当Kir6.2与单独的突变TMD0或与突变SUR1共表达时,开放概率显着增加。 F132L突变破坏了Kir6.2和TMD0之间的物理相互作用,但不改变血浆膜通道密度。我们的结果解释了辅助亚基中的突变如何产生增强的K(ATP)通道孔活性(由Kir6.2形成)。他们还提供了进一步的证据,表明SUR1的TMD0与Kir6.2之间的相互作用对于K(ATP)通道门控至关重要,并在物理和功能水平上鉴定了对此相互作用至关重要的残基。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号